Affinity associated vaccine

Details Affinity associated vaccine Affinity associated vaccine

1995-02-23

1999-04-27

Dees, Jose G.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Liposomes

4242041, 4242061, 4242081, A61K 9127

Patent

active

058978739

ABSTRACT:
Disclosed is a vaccine against an infective agent, the vaccine comprising a liposome having an exterior and an interior and having externally disposed affinity associated antigen material of at least one, preferably nonpartitioning, antigen representative of said infective agent. Also disclosed is a method of preparation and use of this vaccine.

REFERENCES:
patent: 4053585 (1977-10-01), Allison et al.
patent: 4148876 (1979-04-01), Almeida et al.
patent: 4199565 (1980-04-01), Fullerton
patent: 4522803 (1985-06-01), Lenks et al.
patent: 4588578 (1986-05-01), Fountain et al.
patent: 4663161 (1987-05-01), Mannino et al.
patent: 4721612 (1988-01-01), Janoff et al.
patent: 4826687 (1989-05-01), Nerome et al.
patent: 5026557 (1991-06-01), Estis et al.
patent: 5049386 (1991-09-01), Eppstein et al.
patent: 5100662 (1992-03-01), Bolcsak et al.
Alving, et al., Vaccine, 4:166-172, 1986.
Almeida, et al., "Formation of Virsomes from Influenza Subunits and Liposomes", 1975, The Lancet, 899-901.
Alving, Chapter 6 of Liposomes, Marcel Dekker, NY Marc Ostro, ed. pp. 195-218.
Bangham, et al., "Diffusion of Univalent Ions Across the Lamellae of Swollen Phospholipids,", 1965, J. Mol. Biol. 13:238-252.
Bormann, et al., "Synthetic peptides mimic the assembly of transmembrance glycoproteins", Chem. Abs. 110(23), 28025j.
Davis, et al., "Liposomes as adjuvants with immunopurified tetanus toxoid: the immune response", 1986/1987, Immunol. Let. 14:341-348.
Davis, et al., Immunology, 61:229-243, (1987).
Fauci, et al. "Development and Evaluation of a Vaccine for Human Immunodeficiency Virus (HIV) Infection", Annals of Internal Medicine, 110(5):373-385, 1989.
Fauci, et al. "The Development of an AIDS Vaccine: Progress and Promise", Public Health Report, 103(3):230-236, 1988.
Francis, et al., "Immunological Priming with Synthetic Peptides of Foot and Mouth Disease Virus", 1985, J. Gen. Virol. 66:2347-2354.
Gardner, et al., "Animal models of AIDS", FASEB J. 3:2593-2606, Dec. 1989.
Humphries, "Evidence for direct control of an in vitro plaque-forming cell response by quantitative properties of intect, fluid, haptenated liposomes: a potential model system for antigen presentation by macrophages", 1981, J. Immunol. 126(2):688-692.
Kraaijeveld, et al., "The effect of liposomal charge on the netralizing antibody response against inactivated encephalomyocarditis and Semliki Forest viruses", 1984, Clin. Immunol. 56:509-514.
Kramp, et al., "Liposomal Enhancement of the Immunogenicity of Adenovirus Type 5 Hexon and Fiber Vaccines", 1979, Infec. and Immun. 25(2):771-773.
Naylor, et al., "In Vivo Induction of Anti-Herpes Simplex Virus Immune Response by type 1 Antigens and Lipid A Incorporated into Liposomes", 1982, Infec. and Immun. 36(3):1209-1216.
Papahadjapoulos, et al., "Phospholipid Model Membranes I. Structural Characteristics of Hydrated Liquid Crystals," 1967 Biochim. Biophys. Acta, 135:624-638.
Pierce, et al., "Enhancement by lipid A of Mucosal Immunogenicity of Liposome-Associated Cholera Toxin", 1984, Rev. Infect. Dis. 6(4):563-566.
Putney, et al., "HTLV-III/LAV-Neutralizing Antibodies to an E. coli-Produced Fragment of the Virus Envelope", 1986, Science 234:1392-1395.
Siddiqui, et al., "Vaccination of Experimental Monkeys Against Plasmodium falciparum: A Possible Safe Adjuvant", 1978, Sci. 201:1237-1239.
Tan, et al., "Effect of interleukin-2 on the immunoadjuvant action of liposomes", 1989, Biochem. Soc. Trans. 17:693-694.
Tan, et al., "Incorporation of reconstituted influenza virus enveloped into liposomes studies of the immune response in mice", 1989, Biochem. Soc. Trans. 17:129-130.
van Houte, et al., "Characterization of immunogenic properties of haptenated liposomal model membranes in mice I. Thymus Independence of the Antigen", 1979, Immunol. 37:505-514.
van Houte, et al., "Characterization of immunogenic properties of haptenated liposomal model membranes in mice V. Effect of membrane Composition of Huymoral and Cellular Immunogenicity", 1981, Immunol 44:561-568.
van Rooijen, et al., "Liposomes in Immunology: Evidence that their adjuvant effect results from surface exposition of the antigens", 1980, Cell. Immunol, 49:402-407.
Walden, et al., "Induction of regulatory T-lymphocyte responses by liposomes carrying major histocompatibility complex molecules and foreign antigen":, 1985, Nature 315(23):327-329.
Yin, et al., "Effect of Various Adjuvants on the Antibody Response of Mice to Pheumococcal Polysaccharides", 1988, J. Biol. Res. Mod. 8:190-205.
94367959 Medline, "NIH Conference: HIV Vaccine Development: A Progress Report," Hoth et al., Ann. Intern. Med. 121(8)603-611, 1994.
90076756 Medline, "Animal Models of AIDS" Gardner et al., FASEB J. 3(14) 2593-609 (1989).
89133269 Medline "NIH Conference . . . " Fauci et al., Ann. Intern. Med. 110(5) 373-85 (1989).
88234863 Medline, "The development of an AIDS vaccine" . . , Public Health Rep, 103(3) 230-6 (1988).
Davis et al., Immunology, vol. 61, pp. 229-234 (1987).
Alving et al., Vaccine, vol. 4, pp. 166-172, 1986.
Kinsky et al., J. of Immunol. Methods, vol. 65, pp. 295-306, 1983.

Affiliated with

Also associated with

Rating

Affinity associated vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Affinity associated vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Affinity associated vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-684729